Surfing The NASH Tsunami Podcast

Driving The Discussion In Fatty Liver Disease

Drug developers, investors, researchers, and corporate executives…

Every week, a global community of Fatty Liver Disease stakeholders comes together to explore the most important challenges in diagnosing, treating, and developing medications for patients with Fatty Liver Diseases.

Join hepatology researcher and Key Opinion Leader Dr. Stephen Harrison, liver wellness advocate Louise Campbell MSc AP., Forecasting and Pricing guru Roger Green, M.B.A., and their weekly guests as they discuss these issues from their own unique perspectives on the Surfing the NASH Tsunami podcast.

most recent episode ⤵

S3-E47 - What does the next year hold for the NAFLD metabolic disease link?

S3-E47 – What does the next year hold for the NAFLD metabolic disease link?

Surfers Roger Green, Jörn Schattenberg and Louise Campbell embark on their first exclusive discussion together in a while without any guest panelists. After several weeks of attending and reviewing conferences, the trio take the opportunity to talk about what the next year holds for the NAFLD-metabolic disease link.

SurfingNASH.Com is honored to have the following sponsors

Would you like to participate ask a question join the surfers in our next episode?

S3-E44.5 – 1 on 1 with Jeff Lazarus: Focus on NAFLD Summit

In Part 2 of Season 3, Episode 44, host Roger Green kicks off a series of 1 on 1 interviews with friend of the podcast, Dr. Jeffrey Lazarus. In this conversation, the two discuss a preview of NAFLD Summit 2022 in Dublin, 15-17 September.

S3-E44.3 – Anticipated Aftermath: Outcomes of Paris NASH

In this conversation, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to talk about Paris NASH 2022. The group explores their hopes in terms of immediate and long term outcomes of the meeting.

S3-E44.2 – NASH and an Integrated Multi-Specialty Approach

In a preview of the 2022 Paris NASH Meeting, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to discuss the opening session. The group explores potential insights that will contextualize NASH in the scope of an integrated multi-specialty approach.

S3-E44.1 – Paris NASH Meeting Preview: Program Highlights

In a preview of the 2022 Paris NASH Meeting, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to discuss what each looks forward to most in the upcoming panels and discussions. “Brave one go first.”

This is truly an excellent podcast…(verified review) ⭐️⭐️⭐️⭐️⭐️
Read More
This is truly an excellent podcast. Roger Green is joined by Akero Therapeutics' Kitty Yale, Manal Abdelmalek (Duke University), Naim Alkhouri (Arizona Liver Health) and Stephen Harrison from Pinnacle Clinical Research. They go through the FDA's recent webcast and dissect the meaning and directions laid out. Interesting points around histology remaining the surrogate for the evaluation of NASH and how we need to have a better way of quantifying NASH histology
FINALLY!(verified review) ⭐️⭐️⭐️⭐️⭐️
Read More
A podcast for the NASH community! So many relevant topics. There are guest speakers almost every week who contribute a new energy to each episode. Keep up the good work coming!
I learn without trying(verified review) ⭐️⭐️⭐️⭐️⭐️
Read More
The host and other speakers are engaging to listen to yet not too serious or noting. I find mysweldf learning without trying. Excellent to have this on while working at home or driving while running errands.
At Long Last!(verified review) ⭐️⭐️⭐️⭐️⭐️
Read More
We have sorely needed a podcast that allows clinicians and academics to focus own major issues in NASH and NAFLD. Their recent coverage of ILC was timely and incisive. I find myself discussing the episodes with colleagues and Twitter buddies.
Previous
Next

Experience Nudge Learning!
Interested in a new way of learning?